NeoGenomics Inc (NEO)
15.39
+0.03
(+0.20%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Profit Margin (Quarterly): -10.55% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.55% |
| June 30, 2024 | -11.33% |
| March 31, 2024 | -17.32% |
| December 31, 2023 | -9.21% |
| September 30, 2023 | -12.19% |
| June 30, 2023 | -16.56% |
| March 31, 2023 | -22.44% |
| December 31, 2022 | -16.36% |
| September 30, 2022 | -28.62% |
| June 30, 2022 | -28.23% |
| March 31, 2022 | -42.17% |
| December 31, 2021 | -33.21% |
| September 30, 2021 | -16.77% |
| June 30, 2021 | 62.33% |
| March 31, 2021 | -19.14% |
| December 31, 2020 | 12.24% |
| September 30, 2020 | 2.04% |
| June 30, 2020 | -7.85% |
| March 31, 2020 | -6.58% |
| December 31, 2019 | 5.89% |
| September 30, 2019 | 2.05% |
| June 30, 2019 | 1.96% |
| March 31, 2019 | -2.54% |
| December 31, 2018 | 0.46% |
| September 30, 2018 | 2.93% |
| Date | Value |
|---|---|
| June 30, 2018 | -0.56% |
| March 31, 2018 | 1.02% |
| December 31, 2017 | 7.40% |
| September 30, 2017 | -7.21% |
| June 30, 2017 | 0.78% |
| March 31, 2017 | -2.03% |
| December 31, 2016 | -13.78% |
| September 30, 2016 | -0.11% |
| June 30, 2016 | 0.65% |
| March 31, 2016 | 0.26% |
| December 31, 2015 | -5.40% |
| September 30, 2015 | -0.50% |
| June 30, 2015 | -0.72% |
| March 31, 2015 | -3.30% |
| December 31, 2014 | 4.19% |
| September 30, 2014 | -1.25% |
| June 30, 2014 | 1.33% |
| March 31, 2014 | 0.56% |
| December 31, 2013 | 4.68% |
| September 30, 2013 | 5.33% |
| June 30, 2013 | 1.75% |
| March 31, 2013 | 0.02% |
| December 31, 2012 | -0.76% |
| September 30, 2012 | -6.87% |
| June 30, 2012 | 3.53% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.17%
Minimum
Mar 2022
62.33%
Maximum
Jun 2021
-10.80%
Average
-14.27%
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Henry Schein Inc | 3.12% |
| Karyopharm Therapeutics Inc | -82.70% |
| Apellis Pharmaceuticals Inc | -29.19% |
| Beam Therapeutics Inc | -677.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.38% |
| Return on Assets | -4.69% |
| Return on Invested Capital | -5.30% |
| Gross Profit Margin (Quarterly) | 44.62% |
| Operating Margin (Quarterly) | -12.03% |
| Return on Net Operating Assets | -6.23% |